Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 56734/0030.
Nintedanib Advanz Pharma 150 mg soft capsules
Nintedanib Advanz Pharma 150 mg soft capsules
nintedanib
1. What Nintedanib Advanz Pharma is and what it is used for
2. What you need to know before you take Nintedanib Advanz Pharma
3. How to take Nintedanib Advanz Pharma
4. Possible side effects
5. How to store Nintedanib Advanz Pharma
6. Contents of the pack and other information
Nintedanib Advanz Pharma contains the active substance nintedanib, a medicine belonging to the class of so-called tyrosine kinase inhibitors, and it is used for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype and systemic sclerosis associated interstitial lung disease (SSc-ILD) in adults.
Idiopathic pulmonary fibrosis (IPF)
IPF is a condition in which the tissue in your lungs becomes thickened, stiff and scarred over time. As a result, scarring reduces the ability to transfer oxygen from the lungs into the bloodstream and it becomes difficult to breathe deeply. This medicine helps to reduce further scarring and stiffening of the lungs.
Other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype
Besides IPF, there are other conditions in which the tissue in your lungs becomes thickened, stiff, and scarred over time (lung fibrosis) and keeps worsening (progressive phenotype). Examples of these conditions are hypersensitivity pneumonitis, autoimmune ILDs (such as rheumatoid arthritis associated ILD), idiopathic nonspecific interstitial pneumonia, unclassifiable idiopathic interstitial pneumonia, and other ILDs. This medicine helps to reduce further scarring and stiffening of the lungs.
Systemic sclerosis associated interstitial lung disease (SSc-ILD)
Systemic sclerosis (SSc), also known as scleroderma, is a rare chronic autoimmune disease that affects connective tissue in many parts of the body. SSc causes fibrosis (scarring and stiffening) of the skin and other internal organs such as the lungs. When the lungs are affected by fibrosis, it is called interstitial lung disease (ILD), and so the condition is called SSc-ILD. Fibrosis in the lungs reduces the ability to transfer oxygen into the bloodstream, and breathing capacity is reduced. This medicine helps to reduce further scarring and stiffening of the lungs.
Talk to your doctor or pharmacist before taking Nintedanib Advanz Pharma if you:
Based on this information your doctor may do some blood tests, for example to check your liver function. Your doctor will discuss the results of these tests with you and decide whether you may receive Nintedanib Advanz Pharma.
Inform your doctor immediately while taking this medicine if you:
Nintedanib Advanz Pharma should not be taken by children and adolescents under 18 years of age.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including herbal medicines and medicines obtained without a prescription.
Nintedanib Advanz Pharma can interact with certain other medicines. The following medicines are examples that may increase the levels of nintedanib in your blood, and hence may increase the risk for side effects (see section 4):
The following medicines are examples that may lower the levels of nintedanib in your blood and thus may reduce the effectiveness of Nintedanib Advanz Pharma:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Do not take this medicine during pregnancy, as it can harm your unborn baby and cause birth defects.
You must have a pregnancy test done to ensure you are not pregnant before starting treatment with this medicine. Please talk to your doctor.
Contraception
Breast-feeding
Do not breast-feed during the treatment with this medicine since there may be a risk of harm to the breast-fed child.
This medicine may have minor influence on your ability to drive and use machines. You should not drive or use machines if you feel sick.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Take the capsules twice daily approximately 12 hours apart at about the same time every day, for example one capsule in the morning and one capsule in the evening. This ensures that a steady amount of nintedanib is maintained in your blood stream. Swallow the whole capsules with water and do not chew the capsules. It is recommended that you take the capsules with food, for example during or immediately before or after a meal. Do not open or crush the capsule (see section 5).
The recommended dose is one capsule of 150 mg twice daily (a total of 300 mg per day).
Do not take more than the recommended dose of two Nintedanib Advanz Pharma 150 mg capsules per day.
If you do not tolerate the recommended dose of two Nintedanib Advanz Pharma 150 mg capsules per day (see possible side effects in section 4) your doctor may reduce the daily dose of Nintedanib Advanz Pharma. Do not reduce the dose or stop the treatment by yourself without consulting your doctor first.
Your doctor may reduce your recommended dose to 100 mg two times per day (a total of 200 mg per day). In this case your doctor will prescribe Nintedanib Advanz Pharma 100 mg capsules for your treatment. Do not take more than the recommended dose of two Nintedanib Advanz Pharma 100 mg capsules per day if your daily dose was reduced to 200 mg per day.
Contact your doctor or pharmacist immediately.
Do not take two capsules together if you have forgotten to take your earlier dose. You should take your next 150 mg dose of Nintedanib Advanz Pharma as planned at the next scheduled time recommended by your doctor or pharmacist.
Do not stop taking Nintedanib Advanz Pharma without consulting your doctor first. It is important to take this medicine every day, as long as your doctor prescribes it for you.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You need to pay special attention if you get the following side effects during treatment with Nintedanib Advanz Pharma:
Diarrhoea (very common, may affect more than 1 in 10 people):
Diarrhoea may lead to dehydration: a loss of fluid and important salts (electrolytes, such as sodium or potassium) from your body. At the first signs of diarrhoea drink plenty of fluids and contact your doctor immediately. Start appropriate anti-diarrhoeal treatment, e.g. with loperamide, as soon as possible.
Talk to your doctor if you get any side effects.
Idiopathic pulmonary fibrosis (IPF)
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Not known (frequency cannot be estimated from the available data)
Other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Not known (frequency cannot be estimated from the available data)
Systemic sclerosis associated interstitial lung disease (SSc-ILD)
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Not known (frequency cannot be estimated from the available data)
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not use this medicine if you notice that the blister containing the capsules is opened or a capsule is broken.
If you are in contact with the content of the capsule, wash off your hands immediately with plenty of water (see section 3).
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Nintedanib Advanz Pharma 150 mg are brown, opaque and oblong soft capsules containing yellow viscous suspension, imprinted with “NT 150” in blackink and approximately 17 mm in length.
Nintedanib Advanz Pharma 150 mg capsules are available in carton box with OPA/Al/PVC-Aluminum perforated unit dose blisters.
Pack sizes:
60 x 1 soft capsules
This leaflet was last revised in November 2025.